The Ultimate Guide To Piceatannol 4'-O-?-D-glucopyranoside
All enrolled patients who acquired no less than a person dose of zosuquidar or placebo through induction were being monitored for your prevalence of adverse activities (439 clients, 219 on zosuquidar and 210 on placebo). The commonest adverse events were being relevant to the period of prolonged and considerable myelosuppression as is anticipated w